Skip to main content

Carbetapentane / diphenhydramine Pregnancy and Breastfeeding Warnings

Brand names: D-Tann AT, Dytan-AT

Carbetapentane / diphenhydramine Pregnancy Warnings

Carbetapentane-diphenhydramine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbetapentane-diphenhydramine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Carbetapentane / diphenhydramine Breastfeeding Warnings

There are no data on the excretion of carbetapentane-diphenhydramine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

Does Carbetapentane/diphenhydramine interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

References for pregnancy information

  1. (2006) "Product Information. Dytan-AT (carbetapentane-diphenhydramine)." Hawthorn Pharmaceuticals

References for breastfeeding information

  1. (2006) "Product Information. Dytan-AT (carbetapentane-diphenhydramine)." Hawthorn Pharmaceuticals

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.